Monthly Archives: November 2022

Solid-phase synthesis in the amplification and sequencing of nucleic acids

The Oligofastx project covers the different phases of the development of oligonucleotide-based therapies, from design to production, and this is one of the reasons why the consortium is made up of seven companies, each specializing in different phases of the process. Today we talk about solid-phase synthesis. Oligonucleotides are short chains of different “building blocks” […]

Oligonucleotides for curing osteoporosis, premature aging in children and hepatitis B

OLIGOFASTX follows with great interest all the recent advances in the work with oligonucleotides, not only in terms of new lines of research, but also with respect to all the applications that are being developed close to the market. Because it is our ultimate goal and our objective: to provide solutions to diseases that do […]

Maurice Wilkins, the third man of the double helix

History is peppered with stories, legends and tales. And as in all of them, any biography of a person of international relevance, such as the one we are dealing with today, is full of anecdotes, joys and sorrows and betrayals. Recognizing all his valuable contributions, the life of Maurice Wilkins is marked by destiny: the […]